Hip Bone Strength as a Therapeutic Target Working Group

Members

Chairs: ML Bouxsein, S Ferrari
Members: E Biver, C Glüer, M McClung
Co-opted: P Zysset

Aim

To review the experimental and clinical evidence evaluating femoral strength by BMD and/or finite element analysis (FEA), its correlation with the actual strength and its association with hip fracture risk and changes with osteoporosis treatment.

Publications

Publication to come.